Dicaffeine Malate (Infinergy).

Caffeine blocks adenosine receptors and raises sympathetic drive, while theanine increases alpha activity and softens that edge without blunting alertness. The combination is one of the most settled in the category.

Caffeine increases catecholamine signalling, and tyrosine is the amino acid precursor from which dopamine and noradrenaline are built. Supplying the precursor supports the pool the stimulant draws on.

Taurine modulates intracellular calcium handling and membrane excitability in cardiac and neural tissue, which runs counter to the excitatory push of adenosine receptor blockade. It is a standard companion in stimulant formulas for that reason.

Catechins inhibit catechol O methyltransferase, the enzyme that clears noradrenaline, while caffeine inhibits phosphodiesterase and adenosine signalling. The two act at consecutive steps of the same thermogenic cascade.

Beta alanine raises muscle carnosine and intracellular buffering over weeks, while caffeine acts acutely on perceived effort through adenosine blockade. They address different limits in the same session and do not share a pathway.

Caffeine and creatine act on opposite sides of muscle relaxation kinetics, and co ingestion has been reported to reduce the performance gain creatine loading otherwise produces. Splitting the timing is the usual formulation answer.

Adenosine receptor blockade raises arousal and delays sleep pressure, working against the circadian signal melatonin provides. Taken close together each undercuts the other.

Caffeine produces a small, well documented rise in urinary calcium excretion in the hours after intake. Habitual high stimulant intake alongside a modest calcium intake works against calcium balance.

Dicaffeine malate is a caffeine source, so any product that also carries anhydrous caffeine is stacking the same molecule twice. Total caffeine from all sources is what determines the physiological load, not the number of line items on the label. Formulators calculate the combined caffeine base, since dicaffeine malate is only about three quarters caffeine by weight. This is arithmetic rather than a novel interaction.

Green tea extract carries its own native caffeine unless it is specifically decaffeinated. Combined with dicaffeine malate the caffeine contributions add together at the adenosine receptor. Catechins in the extract are metabolised separately and do not offset the stimulant load. Label reading matters here because extract caffeine content varies widely between batches and specifications.

Citrulline raises plasma arginine and supports normal nitric oxide production, while caffeine acts through adenosine receptor antagonism and central drive. The two run on separate pathways that both feed into exercise readiness, which is why pre-workout formulas pair them. No combination trial is being cited for this pairing. Read it as mechanistic rationale plus formulation convention rather than measured additivity.

Dietary nitrate is reduced to nitrite by oral bacteria and then to nitric oxide, supporting normal blood vessel dilation. Caffeine contributes central stimulation through a different receptor system entirely. The pairing is common in performance formulas because the two mechanisms do not overlap. Antibacterial mouthwash blunts the nitrate arm and leaves the caffeine arm untouched.

Alpha-GPC supplies choline for acetylcholine synthesis, a cholinergic input, while caffeine works by blocking adenosine signalling. Two different neurotransmitter systems are involved, so the effects are independent rather than competing. Formulators pair them for combined alertness support. The rationale is mechanistic and not drawn from a head-to-head combination trial.

Rhodiola is used for support of normal stress adaptation and perceived exertion, and caffeine drives central arousal directly. Stacking both raises the total stimulatory input, which matters most for people sensitive to jitteriness or late-day dosing. Sensitive users often stagger the two. The combination has mechanistic logic and thin human data.

Caffeine and the polyphenols that accompany it reduce non-heme iron absorption when taken with an iron-containing meal or supplement. The effect is on absorption at the gut, not on iron already in the body. Separating a caffeine dose from an iron dose by an hour or more sidesteps the interaction. This is settled absorption pharmacology and does not depend on the malate counter-ion.

Caffeine has a mild diuretic action that transiently increases urinary output of magnesium and other cations. Habitual users show substantial tolerance to the diuretic effect. The practical relevance is greatest at high daily caffeine intakes combined with a marginal magnesium intake. This describes a handling effect on a mineral, not a change in magnesium status by itself.

Bicarbonate acts as an extracellular buffer against exercise-induced acid load, and caffeine acts centrally on perceived effort. The mechanisms sit in different compartments so they are commonly combined in performance protocols. Gastrointestinal upset from bicarbonate is the practical limit on the pairing. No combination measurement is offered here.

Glutamine appears alongside caffeine in performance powders mainly as a formulation choice rather than a pharmacological pairing. The two do not share a metabolic route or a transporter. Nothing in the pairing changes caffeine absorption or clearance. It is included here so a formula containing both is read accurately rather than credited with a synergy that has not been shown.

Valerian is used for support of normal sleep onset and caffeine antagonises adenosine signalling that builds sleep pressure. Taken in the same window the two work against each other on the same behavioural endpoint. Time separation is the standard handling. This is opposing pharmacology rather than a toxicity concern.

Chamomile is taken for calm and evening wind-down, while caffeine from dicaffeine malate maintains alertness for hours after dosing. Caffeine's half life in most adults spans several hours, so an afternoon dose can still be active at bedtime. The two therefore pull in opposite directions when scheduled close together. Dose timing, not dose size alone, is the variable that matters.